logo
Gaza ‘mass grave' for Palestinians and those helping them: MSF

Gaza ‘mass grave' for Palestinians and those helping them: MSF

Yahoo16-04-2025

Palestinian lives are being systematically destroyed as Israel's continued bombardment of the Gaza Strip shows a 'blatant disregard' for the safety of humanitarian workers, according to medical aid agency Doctors Without Borders (MSF).
Amande Bazerolle, MSF's emergency coordinator in the enclave, said in a statement on Wednesday, 'Gaza has been turned into a mass grave of Palestinians and those coming to their assistance.'
Last month, Israeli forces opened fire on ambulances in Gaza, killing 15 medics and rescuers in an incident that prompted international condemnation.
'We are witnessing in real time the destruction and forced displacement of the entire population in Gaza,' she said.
Medical facilities are not exempt from attacks and evacuation orders by Israeli forces. MSF teams have had to leave many facilities, while others continue operating with staff and patients trapped inside, unable to leave safely for hours at a time, the charity said.
'With nowhere safe for Palestinians or those trying to help them, the humanitarian response is severely struggling under the weight of insecurity and critical supply shortages, leaving people with few, if any, options for accessing care,' Bazerolle said.
Israel resumed aerial bombardment and ground operations in the Palestinian territory in March after it reneged on a two-month-old ceasefire. Thousands of people have since been killed, with many more displaced. Israel has also blocked humanitarian aid from entering Gaza since March 2.
Medical supplies, fuel, water and other essentials are in short supply, the United Nations says.
On Wednesday, Defence Minister Israel Katz said Israel's 'policy is clear and no humanitarian aid will be allowed into Gaza' as it is 'one of the main pressure tools' against Hamas.
'In the current reality, no one is going to allow any humanitarian aid into Gaza, and no preparations are being made to allow any aid of this kind,' he said.
Israeli forces 'will remain in the security zones as a buffer between the enemy and [Israeli] communities in any temporary or permanent situation in Gaza', he said.
Al Jazeera's Nour Odeh, reporting from Jordan's capital, Amman, said the ongoing mediated efforts to get Israel and Hamas to agree on a new ceasefire seem to have reached 'a dead end'.
'Israel is trying to extort a temporary ceasefire deal in exchange for allowing critically needed aid back to Gaza. Israel will also only promise to discuss ending its genocidal war on Gaza if Hamas agrees to disarm and exile up to 200 of its members from the Strip,' she said.
'Hamas has shown flexibility on many issues, but the movement says laying down its arms without ending the occupation is a red line. But Hamas is running out of options. Gaza is in ruins. People are running out of hope and patience,' Odeh added.
Israeli forces have taken over large areas of Gaza in recent weeks. Together with the blockade, continued fighting has worsened the already catastrophic humanitarian situation in Gaza.
At least 51,000 people, most of them children and women, have been killed in Israeli attacks since October 2023.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Over 100 reported killed in Gaza in 24 hours as telecoms go down
Over 100 reported killed in Gaza in 24 hours as telecoms go down

Yahoo

timea day ago

  • Yahoo

Over 100 reported killed in Gaza in 24 hours as telecoms go down

More than 100 people were reported killed in Israeli strikes on Gaza within 24 hours, as deadly incidents near aid distribution sites and a major communications outage deepened the crisis in the war-shattered Palestinian territory on Thursday. The Health Ministry in Gaza, controlled by Hamas, reported 103 deaths and 427 injuries in the past day alone. The ministry does not distinguish between civilians and combatants, and the figures could not be independently verified. Since the start of the war on October 7, 2023, which was triggered by a Hamas-led attack on southern Israel that killed around 1,200 people and saw more than 250 taken hostage, more than 55,200 people have been killed in Gaza and over 127,800 injured, according to the ministry. Palestinians reported that Israeli forces opened fire near aid distribution positions, while a humanitarian foundation said Hamas launched a deadly attack on its staff. The Palestinian news agency WAFA said at least 13 people were killed and around 200 injured at an aid centre in the Netzarim Corridor in central Gaza. The Hamas-run Health Ministry confirmed the incident, but put the toll at 10 dead and at least 120 wounded. Separately, WAFA reported five more deaths in the Sudaniya area north-west of Gaza City, where people were waiting for food assistance. The Israeli military has not commented on the incidents. The Gaza Humanitarian Foundation (GHF), supported by Israel and the United States, began distributing aid last month following a near three-month Israeli blockade. The initiative aims to prevent Hamas from diverting aid, according to Israeli officials. However, the operation has drawn criticism from the UN and humanitarian organizations, who cite safety and access concerns. The GHF said that a Hamas attack on one of its staff buses killed eight Palestinian employees and injured several others on Wednesday evening. The team was en route to a distribution centre west of Khan Younis in southern Gaza. The foundation stated that some employees may have been taken hostage and that it was still gathering information. "These were aid workers. Humanitarians. Fathers, brothers, sons, and friends," GHF said, condemning what it called a "heinous and deliberate attack." The organization urged the international community to hold Hamas accountable, saying its staff had been targeted simply for delivering food to Palestinians. WAFA, citing medical sources, reported that 224 people have been killed and over 1,850 injured around aid distribution points since May 27. 'The points have become traps for mass killings,' the agency said. Communications blackout adds to chaos Also on Thursday, Gaza's last functioning fibre-optic network was damaged in an attack, resulting in a complete outage of internet and landline services, according to the Palestinian Telecommunications Authority. WAFA said the blackout would have severe humanitarian and social consequences and called for immediate restoration. Telecommunications have been repeatedly disrupted during the conflict, hampering relief coordination and civilian communication. Israel has been engaged in a sustained military campaign in Gaza for 20 months, with the stated goal of eliminating Hamas and securing the release of remaining hostages. A new major ground offensive was launched nearly a month ago. The campaign has drawn international criticism, including from Israel's close allies, over the mounting civilian toll and the humanitarian situation on the ground.

Apex Labs Granted Israel MoH Approval to Expand Phase 2b Macrodose Psilocybin PTSD Clinical Trial
Apex Labs Granted Israel MoH Approval to Expand Phase 2b Macrodose Psilocybin PTSD Clinical Trial

Yahoo

timea day ago

  • Yahoo

Apex Labs Granted Israel MoH Approval to Expand Phase 2b Macrodose Psilocybin PTSD Clinical Trial

Israel's Ministry of Health (MoH) approval to add additional sites to APEX SUMMIT-90 160 patient phase 2b macrodose clinical trial: Tel Aviv University (TAU)'s Institute for Psychedelic Research located at the Sagol Brain Institute (SGI) in Tel-Aviv Sourasky Medical Center. Be'er Yaakov Mental Hospital (Merhavim) Center for Psychedelic Studies. For more information or to register visit (Canada) and (Israel). VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with psilocybin is pleased to announce the approval by the Israeli MoH and IRBs to open two additional clinical trial sites for SUMMIT-90. The trial is a double-blind, placebo controlled phase 2b study evaluating multiple doses of APEX-90, a psilocybin macrodose utilizing APEX's US patent pending capsule. APEX-90 is administered in-clinic with study-assisted psychotherapy for severe depression within diagnosed PTSD. Israel is facing a severe mental health crisis: 44% of adults report depression and 42% PTSD, far above the 8–13% depression and 6–10% PTSD rates seen in the US and Canada. This MoH approval leverages the expertise of TAU's renowned SGI and Merhavim Hospital, which both have a rich history of pioneering research in neurological sciences. Their cutting-edge facilities and teams profound understanding of PTSD dynamics are poised to add patient recruitment expertise. 'I am honoured to have been able to facilitate this new partnership; another example of building important bridges between Canada and Israel in innovative clinical research, which will result in advancing patient access to emerging treatments,' says Sharon J. Fraenkel, TAU Canada's CEO for Ottawa, Quebec, and Atlantic Canada, on behalf of the organization. 'As someone deeply connected to Israel, witnessing the toll of PTSD among my loved ones, I'm driven to lead research that brings hope and healing,' says Alysa Langburt, APEX's VP of Global Clinical Development. 'This marks more than a clinical milestone, it represents a fundamental step towards transforming the mental health landscape in Canada and Israel, where the need has never been greater. Through our incredible partnerships, we aim to catalyze a shift in access, care and outcomes for those suffering with PTSD.' "SUMMIT-90 offers a beacon of hope for the significant numbers suffering from PTSD in Canada and Israel,' says Tyler Powell, co-Founder and CEO of APEX. 'It underscores our commitment to global mental health innovation and our belief in the opportunity for clinically proven psilocybin therapies to transform mental health care.' About Apex Labs is a patient-driven pharmaceutical company focused on revolutionizing the standard of mental health care with psilocybin. APEX's strategy is two-pronged, clinical evaluation of drug assets alongside a robust Early Access Program. APEX recognizes and prioritizes Veterans as a patient base with the most severe unmet medical need. Visit for more information and follow APEX on LinkedIn, Twitter and Instagram. Forward-Looking StatementsThis release contains certain "forward-looking statements" and certain "forward-looking information" as defined under applicable Canadian securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as "may", "will", "expect", "intend", "estimate", "anticipate", "believe", "continue", "plans" or similar terminology. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability to control or predict, that may cause the Company's actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out here in, including but not limited to: receiving authorization of Health Canada Dealers Licence; filing US provisional patent, the Company evaluating the safety and efficacy of APEX-52 (psilocybin) and APEX-90 (psilocybin) in treating depression in Veterans and patients with Post-Traumatic Stress Disorder; statements related to APEX-52 and APEX-90, including manufacturing, dosing, and trial details; statements made by the Company's executives with respect to Health Canada's Dealer's Licence and capsule patent filing; the Company's efforts around the Early Access Program; statements made relating to Canadian Veteran patients; approvals by the Israeli Ministry of Health and ethics; the inherent risks involved in the general securities markets; uncertainties relating to the availability and costs of financing needed in the future; the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, currency fluctuations; regulatory restrictions, liability, competition, loss of key employees and other related risks and uncertainties. The Company undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents managements' best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information. SOURCE Apex Labs Ltd. CONTACT: For further information: info@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Syrian girl receives life-saving treatment at Rambam Hospital in Haifa
Syrian girl receives life-saving treatment at Rambam Hospital in Haifa

Yahoo

time2 days ago

  • Yahoo

Syrian girl receives life-saving treatment at Rambam Hospital in Haifa

The evacuation and treatment of Syrians at Israeli hospitals have been a part of ongoing humanitarian initiatives, with full approval from military censors to ensure safety and well-being. A 12-year-oldSyrian girl who was critically ill due to a heart problem received life-saving treatment at Rambam Health Care Campus in Haifa last week, following a joint humanitarian effort between the IDF and the "Yitro - Jews for Druze" association. The young girl was evacuated from southern Syria last Thursday and brought to the Ruth Rappaport Children's Hospital at Rambam. She was in a life-threatening condition, requiring urgent medical care. Accompanied by her mother, the girl underwent a medical procedure in the pediatric intensive care unit to treat her heart issue. After four days of intensive care, her condition improved significantly, and she was released in stable condition. Following her discharge from the hospital, the girl was transferred back to the IDF, which arranged for her safe return to a meeting point in southern Syria to reunite with her father. Mr. Amnon Bartel, chairman of the Yitro Association, expressed his gratitude to the IDF for making the operation possible and praised Rambam Health Care Campus for its professional medical care. "This complex and moving humanitarian effort exemplifies our commitment to saving lives. Rambam and the Yitro Foundation will continue to work together to provide medical excellence and support to those in need," said Bartel. The evacuation and treatment of Syrians at Israeli hospitals have been a part of ongoing humanitarian initiatives, with full approval from military censors to ensure the safety and well-being of all parties involved.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store